Press Releases Biotest AG

Equities

BIO3

DE0005227235

Market Closed - Xetra Other stock markets 11:36:02 2024-05-06 am EDT			5-day change	1st Jan Change
28 ^EUR	-2.10%		-2.44%	-9.68%

Apr. 19	Biotest Launches New Plasma Collection Center in Germany	MT
Mar. 28	Biotest Aktiengesellschaft Reports Earnings Results for the Full Year Ended December 31, 2023	CI

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Biotest AG opens 12th plasma collection centre in Germany	Apr. 19	EQ
Biotest AG increased sales by 32% in the financial year 2023	Mar. 28	EQ
Biotest : Sustainability report Declaration of compliance 2023	Mar. 28	PU
Biotest : Invitation / Agenda of Annual General Meeting 2024	Mar. 25	PU
Biotest : Notes on agenda item 1 - German Version	Mar. 24	PU
Biotest achieves EBIT forecast for 2023	Feb. 29	EQ
Karl Lauterbach visits Biotest AG's plasma donation centre in Cologne and emphasises important contribution to patient care	Feb. 28	EQ
Biotest successfully meets primary endpoint in phase III trial with Fibrinogen concentrate	Feb. 14	EQ
AFR: Biotest AG: Preliminary announcement of the publication of financial reports according to Articles 114, 115, 117 of the WpHG [the German Securities Act]	Jan. 30	EQ
AFR: Biotest AG: Preliminary announcement of the publication of financial reports according to Articles 114, 115, 117 of the WpHG [the German Securities Act]	Jan. 22	EQ
Biotest AG opens 11th plasma collection centre in Germany	Jan. 18	EQ
AFR: Biotest AG: Preliminary announcement of the publication of financial reports according to Articles 114, 115, 117 of the WpHG [the German Securities Act]	Jan. 11	EQ
Biotest expands its clinical development program for trimodulin to patients with community-acquired pneumonia (CAP)	Dec. 12	EQ
Biotest’s Trimodulin shows reduced mortality in patients with severe community-acquired pneumonia through rapid normalisation of inflammation	Nov. 28	EQ
Biotest increases EBIT to Euro 125.4 million in the first nine months of 2023	Nov. 02	EQ
Biotest AG: Increase of the EBIT guidance	23-10-05	EQ
Biotest AG: Peter Janssen appointed new Chairman of the Board of Biotest AG	23-10-05	EQ
Biotest AG: Biotest receives approval for innovative immunoglobulin Yimmugo® in the UK	23-09-21	EQ
Biotest AG: Biotest treats first patient with severe community-acquired pneumonia in phase III trial with trimodulin	23-09-12	EQ
Biotest AG: US Food and Drug Administration FDA accepts marketing authorization application for immunoglobulin Yimmugo	23-09-07	EQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases Biotest AG

Equities

BIO3

DE0005227235

Press Releases

Filters